Showing posts with label Pathophysiology. Show all posts
Showing posts with label Pathophysiology. Show all posts

Pathophysiology of Neonatal Sepsis

Pathophysiology of Neonatal Sepsis

Nursing Care Plan for Neonatal Sepsis

Neonatal sepsis is a major health problem globally. Neonatal sepsis is a blood infection that occurs in an infant younger than 90 days old. Early-onset sepsis is seen in the first week of life. Late-onset sepsis occurs between days 8 and 89. Of newborns with early-onset sepsis, 85% present within 24 hours, 5% present at 24-48 hours, and a smaller percentage present within 48-72 hours. Onset is most rapid in premature neonates.

The baby gets the infection from the mother before or during delivery. The microorganisms most commonly associated with early-onset infection include the following :
  • Group B Streptococcus (GBS)
  • Escherichia coli
  • Coagulase-negative Staphylococcus
  • Haemophilus influenzae
  • Listeria monocytogenes
Symptoms of Infants with neonatal sepsis may have the following :
  • Body temperature changes
  • Breathing problems
  • Diarrhea
  • Low blood sugar
  • Reduced movements
  • Reduced sucking
  • Seizures
  • Slow heart rate
  • Swollen belly area
  • Vomiting
  • Yellow skin and whites of the eyes (jaundice)

Pathophysiology of Neonatal Sepsis
Neonates are particularly vulnerable to infection as a result of lower non-specific immunity (inflammation) and specific (humoral), such as low phagocytosis, chemotaxis response delay, minimal or absence of immunoglobulin A and immunoglobulin M (IgA and IgM), and low levels of complement.

Sepsis in the neonatal period can be obtained before birth through the placenta from the maternal blood stream or during labor for ingestion or aspiration of infected amniotic fluid.

Sepsis early (less than 3 days) obtained in the perinatal period, infection can occur from direct contact with the organism from the gastrointestinal or genitourinary tract maternal. The most frequent infecting organism is group B streptococcus (GBS) and Escherichia coli, which is present in the vagina. GBS emerged as a highly virulent microorganisms in the neonate, with a high mortality rate (50%) in infants exposed to Haemophilus influenzae and Staphylococcus negative coagulation are also often seen in early-onset sepsis in infants with very low birth weight.

Advanced Sepsis (1 to 3 weeks after birth) primarily nosocomial, and organisms that attack is usually staphylococci, Klebsiella, enterococcus and pseudomonas. Coagulation negative staphylococci, commonly found as the cause of septicemia in infants of low birth weight and very low birth weight. Bacterial invasion can occur through such Gated umbilical stump, skin, mucous membranes of eyes, nose, pharynx, and ear, and internal systems such as the respiratory system, nervous, urinary, and gastrointestinal.

Postnatal infection, derived from cross-contamination with other babies, personnel, or objects in the environment. Bacteria commonly found in water sources, a humidifier, sink pipes, suction machines, most equipment respiration, and arterial and venous catheters inserted used for infusion, blood sampling, monitoring of vital signs. (Donna L. Wong, 2009).

The process begins with the invasion of the pathophysiology of bacterial sepsis and systemic contamination.
The release of endotoxin by bacteria cause changes in the function of the myocardium, changes in uptake and utilization of oxygen inhibition of mitochondrial function, and progressive metabolic chaos. In sepsis sudden and severe, complemen cascade caused much death and damage cells. The result is a decrease in tissue perfusion, metabolic acidosis, and shock, disseminated intravascular coagulation resulting (DIC) and death. (Bobak, 2004).

Patients with immune disorders have an increased risk for serious nosocomial sepsis. Cardiopulmonary manifestations of gram-negative sepsis can be replicated by injection of endotoxin or Tumor Necrosis Factor (TNF). Barriers to employment TNF by anti-TNF monoclonal antibody greatly weakens manifestation of septic shock. When the bacterial cell wall components are released in the bloodstream, cytokine-activated, and can further lead to more physiological mess. Either alone or in combination, bacterial products and pro-inflammatory cytokines trigger a physiological response to stop the invaders (invader) microbes. TNF and other inflammatory mediators increase vascular permeability and vascular tone imbalance, and the imbalance between perfusion and increased metabolic needs of the network.

Shock is defined as a systolic pressure below the 5th percentile for age or defined with cold extremities. Capillary refilling the late (more than 2 seconds) is seen as a reliable indicator of a decrease in peripheral perfusion. Peripheral vascular pressure in septic shock (heat) but be very up on a further shock (cold). In septic shock tissue oxygen consumption exceeds oxygen supply. This imbalance is caused by peripheral vasodilatation in the beginning, during further vasoconstriction, myocardial depression, hypotension, ventilator insufficiency, anemia. (Nelson, 1999).

Septicaemia shows the emergence of a systemic infection of the blood caused by the rapid multiplication of microorganisms or toxic substances, which can cause huge psychological change. These substances can be pathogenic bacteria, fungi, viruses, and rickets. The most common cause of septicemia is a gram-negative organisms. If the protection of the body is not effective in controlling the invasion of microorganisms, septic shock may occur, which is characterized by hemodynamic changes, imbalance of cellular functions, and multiple system failures. (Marilynn E. Doenges, 1999).

Pathophysiology and Clinical Manifestations of Myasthenia Gravis

Pathophysiology and Clinical Manifestations of Myasthenia Gravis

Nursing Care Plan for Myasthenia Gravis

Myasthenia Gravis

Myasthenia gravis is an autoimmune disease of the neuromuscular junction, the contact point between nerves and muscles. The muscles under our voluntary control become easily tired and weak because there is a problem with how the nerves stimulate the contraction of muscles. For some unknown reason, the body's immune system, which normally helps fight infections, attacks the acetylcholine receptors found on muscles. Myasthenia gravis is almost twice as common in women as in men. It is most commonly found in women under 40 and men over 60. For some people, myasthenia gravis can go into remission and they do not need medicines. The remission can be temporary or permanent.

Clinical Manifestations of Myasthenia Gravis

Clinical manifestations that arise in cases of myasthenia gravis varies from each class, however, in patients with signs and symptoms of myasthenia gravis may occur, namely:
  • Disorders of the eye such as the diplopia (double vision), ptosis (eyelid weakness).
  • Disorders of the facial muscles such as difficulty chewing, swallowing and talking.
  • Disorders of the palatal and pharyngeal muscle weakness, so that the patient is not able to swallow and it is the risk of aspiration.
  • Weakness of neck muscles so the patient's head is hard upright.
  • Weakness of the respiratory muscles such as the diaphragm and intercostal muscles resulted in disruption of breathing.
  • Myasthenia crisis, caused by deficiency of acetylcholine, a condition caused by changes or drug dependence, emotional and physical stress, infection or surgery.
  • Cholinergic crisis, caused by the excess of acetylcholine as a result of an overdose of medication / toxic effects of the administration of acetylcholine.

Signs and symptoms of Myasthenia Crisis and Cholinergic Crisis, namely:

Myasthenia crisis:
  • increased blood pressure
  • tachycardia
  • restless
  • fear
  • increased bronchial secretions, tears and sweat
  • generalized muscle weakness
  • loss of reflex cough
  • difficulty breathing, swallowing and speech
  • decrease in urine output
Cholinergic crisis:
  • decreased blood pressure
  • bradycardia
  • restless
  • fear
  • increased bronchial secretions, tears and sweat
  • generalized muscle weakness
  • difficulty breathing, swallowing and speech
  • nausea, vomiting
  • diarrhea
  • abdominal cramps.

Pathophysiology of Myasthenia Gravis

Basic abnormality in myasthenia gravis is a defect in the transmission of nerve impulses into the muscle cells due to loss of ability or loss of normal membrane receptors postsynapse the neuromuscular connection. The study showed a decrease in 70% to 90% of acetylcholine receptors at the neuromuscular connection, on each individual. Myasthenia gravis is an autoimmune disease that is considered to be directly against the acetylcholine receptor (ACHR) which damage the neuromuscular transmission.
In myasthenia gravis, the immune system produces antibodies that attack one type of receptor on the muscle side of the neuromuscular junction-receptors that respond to the neurotransmitter acetylcholine. As a result, communication between nerve and muscle cells disrupted. What causes the body to attack its own acetylcholine-receptor-unknown autoimmune reaction. According to one theory, damage to the thymus gland may be involved. In the thymus gland, certain cells of the immune system to learn how to distinguish between the body and foreign substances. The thymus gland also contains muscle cells (myocytes) with acetylcholine receptors. For unknown reasons, the thymus gland can instruct cells of the immune system to produce antibodies that attack the acetylcholine receptors. People can inherit a predisposition to autoimmune disorders. about 65% of people who have myasthenia gravis have an enlarged thymus gland, and about 10% had a tumor of the thymus gland (thymoma). Approximately half of thymomas are cancer (malignant). Some people with the disorder do not have antibodies to acetylcholine receptors but have antibodies against the enzyme involved in the formation of the neuromuscular junction instead. These people may require different treatment.